References
- PanaymJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev20035532934712628320
- Garcia-CarboneroRSupkoJGCurrent perspectives on the clinical experience, pharmacology and continued development of the camptothecinsClin Cancer Res2002864166111895891
- IyerLRatainMJClinical pharmacology of camptothecinsCancer Chem Pharm199842S31S34
- Erickson-MillerCLMayRDTomaszewskiJDifferential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitroCancer Chem Pharm199739467472
- LiuLFDesaiSDLiTKMaoYSunMSimSPMechanism of action of camptothecinAnn N Y Acad Sci200092211011193884
- FassbergJStellaVJA kinetic and mechanistic study of the hydrolysis of camptothecin and some analoguesJ Pharm Sci1992816766841403703
- DerakhshandehKDadashzadehSErfanMEncapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kineticsEur J Pharm biopharm200766344117070678
- LuWHanXLiuJ9-NC loaded folate-conjugated polymer micelles as tumor targeted drug delivery systems: preparation and evaluation in vitroInt J Pharm200937212513119166923
- LuJLWangJCZhaoSXSelf-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenograft in nude miceEur J Pharm Biopharm20086989990718434109
- ArbukSGTakimotoCHAn overview of topoisomerase I targeting agentsSemin Hematol199835312
- DalwadiGSunderlandBAn ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticlesEur J Pharm Biopharm200971223124218768159
- BeletsiAPanagiZAvgoustakisKBiodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymersInt J Pharm200529823324115936907
- YanXScherphofGLKampsJAAMLiposome opsonizationJ Liposome Res20051510913916194930
- GaucherGDufresneMHSantVPKangNMaysingerDLerouxJCBlock copolymer micelles: preparation, characterization and application in drug deliveryJ Control Release200510916918816289422
- PeracchiaMTHarnischSPinto-AlphandaryHVisualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticlesBiomaterials1999201269127510403044
- OwensDEPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
- PorterCJHMoghimiSMIllumLDavisSSThe polyoxyethylene polyoxypropylene block copolymer Poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial-cells of rabbit bone-marrowFEBS Letter1992b3056266
- GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
- KwonGSOkanoTPolymeric micelles as new drug carriersAdv Drug Deliv Rev199621107116
- XiongXYLiYPLiZLVesicles from pluronic/poly (lactic acid) block copolymers as new carriers for oral insulin deliveryJ Control Release20071201–211717509718
- Fernandez-CarballoidoAPastorizaPBaricaEMontejoCNegroSPLGA/PEG derivative polymeric matrix for drug delivery system application: characterization and cell viability studiesInt J Pharm2008352505718036755
- LetchfordKBurtHA review of the formulation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomesEur J Pharm Biopharm200765325926917196803
- PaciottiGFKingstonDGITamarkinLColloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctionaltumor-targeted drug delivery vectorsDrug Deliv Res2006674754
- KlumppCKostarelosKPratoMBiancoAFunctionalized carbon nanotubes as emerging nanovectors for the delivery of therapeuticsBiochimica et Biophysica Acta2006175840441216307724
- VonarbourgAPassiraniCSaulnierPBenoitJPParameters influencing the stealthiness of colloidal drug delivery systemsBiomaterials2006274356437316650890
- KostarelosKRational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface scienceAdv Colloid Interface Sci200310614716814672846
- HubbellJAEnhancing drug functionScience200330059559612714733
- AllenTMCullisPRDrug delivery systems: entering the mainstreamScience20043031818182215031496
- SavicRLuoLEisenbergAMaysingerDMicellar nanocontainers distribute to defined cytoplasmic organellesScience200330061561812714738
- DanhierFLecouturierNVromanBPaclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluationJ Control Release2009133111718950666
- HuYXieJTongYWWangCHEffect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cellsJ Control Release2007118171717241684
- BurtHMLigginsRTPolyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulationsAdv Drug Deliv Rev20025419120211897145
- LiuWYangAYangLLiZXuHYangXTumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluationInt J Pharm200733112313217097246
- AvgoustakisKBeletsiAPanagiZKlepetsanisPKarydasAGIthakissiosDSPLGAmPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood propertiesJ Control Release20027912313511853924
- BakerRWLonsdaleHKControlled release of biologically active agentTanquaryACLaceyRNew YorkPlenum Press19741571
- HixsonAWCrowellJHDependence of reaction velocity upon surface and agitation. 1. Theoretical considerationInd Eng Chem193123923931
- GaoJMingJHecBFancYGucZZhangXPreparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin deliveryEur J Pharm Sci200834859318417323
- GaoJMMingJHeBGuZWZhangXDControlled release of 9-nitro-20(S)-camptothecin from methoxy poly(ethylene glycol)-poly(D,L-lactide) micellesBiomed Mater2008301501318458500